Neural regrowth induced by PLGA nerve conduits and neurotrophin-3 in rats with complete spinal cord transection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21384547.
- Also identified by DOI 10.1002/jbm.b.31810.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biomaterials and neurotrophic factors represent two promising strategies for spinal cord injury repair. In this study, a combinatorial approach combining the PLGA nerve conduits and the recombinant human neurotrophin-3 (rhNT3) was utilized in a spinal cord injury animal model. After complete transection of the thoracic cord in rats, rhNT3 was administered as a single dose to the host cord caudal to a 2-mm conduit. Axonal regrowth was enhanced, as indicated by immunostaining and neurofilament-positive area measurement. Neural regrowth was further demonstrated via the retrograde tracing across the lesion. The animals implanted with the PLGA scaffold and rhNT3 exhibited significantly improved performance in BBB rating scale and grid walk tests. These observations suggest that PLGA nerve conduits combined with exogenous NT3 may serve as an alternative therapeutic approach for spinal cord injury repair.
Medical subject headings
- Lactic Acid
- Neurotrophin 3
- Polyglycolic Acid
- Recombinant Proteins
- Spinal Cord Injuries
- Spinal Cord Regeneration